Send a Tweet
Most Popular Choices
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Tell A Friend Printer Friendly Page Save As Favorite View Favorites
OpEdNews Op Eds

Fully funding the TB response is a smart investment

By   Follow Me on Twitter     Message Citizen News Service - CNS       (Page 1 of 3 pages)     Permalink    (# of views)   1 comment

Related Topic(s): ; ; ; ; ; ; ; ; ; , Add Tags
Add to My Group(s)

Must Read 1   Well Said 1   Valuable 1  
View Ratings | Rate It Headlined to H4 10/1/18

Author 91838
Become a Fan
  (1 fan)
- Advertisement -
Shobha Shukla, CNS (Citizen News Service)

Sustained financing is critical cog in the wheel to #endTB: Willo Brock
(Image by CNS (Citizen News Service))
  Permission   Details   DMCA

(CNS): As per WHO's Global TB Report 2018 financing for TB prevention, diagnosis and treatment continues to fall short of the amount needed and commitments from both domestic and international donor sources need to be stepped up.

- Advertisement -

Recognising this lack of sufficient and sustainable financing, the political declaration issued by member states at the recent first-ever UN High Level Meeting (UNHLM) to #endTB commits to increase the overall global investments for ending TB to reach at least US$ 13 billion a year by 2022; and also commits to close the estimated US$ 1.3 billion annual gap in funding for TB research, ensuring that all countries contribute appropriately to TB research and development.

- Advertisement -

Willo Brock, Senior Vice President (External Affairs) at TB Alliance (Global Alliance for TB Drug Development), has extensive experience in resource mobilization in global health. He was in exclusive conversation with CNS (Citizen News Service) on the sidelines of the UNHLM to end TB in New York. Willo provides strategic leadership to the organisation's fundraising, advocacy and policy, and community and stakeholder engagement work.

Here are some excerpts from the interview:

CNS: Why do governments not see investing in TB as a smart business case, despite evidence that for every $1spent on reducing TB incidence can generate benefit of $33?

- Advertisement -

Willo Brock: "It is true that TB creates huge financial burden on people and economies. Even in those countries where diagnostics and treatment costs are covered by the public healthcare system, families are known to spent about half their income on managing their TB treatment. According to one study, it is estimated that multidrug-resistant TB (MDR-TB) alone would cost the global economy a cumulative $16.7 trillion by 2050 and claim the lives of up to 75 million people. So there is big impetus to act. But the costs and the benefits are not at the same scale. Costs are often borne by poor families and not necessarily by the governments. Also, the investments in drug development do not yield immediate gains as R&D is a long term process. But politicians tend to like short term results and not long term investments that give return over a long time period.

CNS: Why has the private sector not been that proactive in funding the fight against TB?

Next Page  1  |  2  |  3


- Advertisement -

Must Read 1   Well Said 1   Valuable 1  
View Ratings | Rate It

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: or @cns_health or

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon Share Author on Social Media   Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Oxygen therapy is like a prescription drug: Use it rationally

Progress made but work remains on firewalling health policy from tobacco industry

World Health Day: No substitute to healthy mind

Nepal leading tobacco control in South Asia: Will it spiral domino effect on other nations?


The time limit for entering new comments on this article has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

1 people are discussing this page, with 1 comments


Become a Fan
Author 28059

(Member since Dec 20, 2008), 21 fans, 3 articles, 15919 comments

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon

  New Content

Very valuable, thanks.

Submitted on Tuesday, Oct 9, 2018 at 2:39:44 AM

Author 0
Add New Comment
Share Comment
Reply To This   Recommend  (0+)

Want to post your own comment on this Article? Post Comment